North America Diagnostic Imaging Market to Reach US$ 14.09 Billion by 2031; United States Leads with 70% Share | Key Players: FUJIFILM Healthcare, GE HealthCare, Philips, Canon Medical Systems

Market Overview

The North America Diagnostic Imaging Market reached US$ 9.7 billion in 2023 and is projected to reach US$ 14.09 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031. Diagnostic imaging encompasses a variety of techniques used to visualize the internal structures of the body, aiding in the identification of illness, injury, or disease progression. These imaging procedures also help clinicians evaluate treatment effectiveness, monitor recovery, and guide therapeutic decisions for conditions such as fractures, cardiovascular diseases, cancer, and other chronic illnesses.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/north-america-diagnostic-imaging-market?Juli

The region's diagnostic imaging portfolio includes MRI and MRA scans, CT scans, ultrasound, bone density scans, mammography, X-rays, arthrograms, and myelograms. Advanced imaging technologies are critical for accurate diagnosis, early detection of diseases, and assessment of therapy outcomes, making them integral to patient care and treatment planning across hospitals, diagnostic centers, and specialty clinics in North America.

Recent Key Developments:

✅ January 2026 - United States: GE HealthCare expanded its diagnostic imaging portfolio with the commercial launch of enhanced AI‐integrated MRI and CT solutions aimed at improving diagnostic workflows and reducing scan times across major healthcare systems.

✅ December 2025 - United States: Canon Medical Systems introduced updated versions of its high‐resolution CT scanners with advanced image reconstruction and dose‐reduction technologies, increasing adoption in major hospital networks.

✅ November 2025 - Canada: Siemens Healthineers inaugurated a new regional innovation center focused on developing next‐generation imaging software and AI‐enabled workflow tools designed for North American radiology practices.

✅ October 2025 - United States: Philips Healthcare announced the rollout of its next‐generation ultrasound systems with enhanced automation and cloud‐based image management capabilities to improve diagnostic efficiency in outpatient and mobile care settings.

✅ August 2025 - United States: Hologic, Inc. expanded distribution of its advanced 3D mammography systems, with new clinical partnerships aimed at strengthening breast cancer screening programs across multiple states.

Latest Mergers & Acquisitions:
✅ August 2025: Phillips Healthcare acquired CardioScan Analytics, a North America-based cardiac imaging analytics company, to deepen its presence in AI‐driven cardiovascular diagnostic solutions.

✅ June 2025: Hologic, Inc. announced the acquisition of Precision Breast Diagnostics, a U.S. firm specializing in advanced mammography interpretation software and breast imaging analytics.

✅ April 2025: Fujifilm Healthcare completed the acquisition of MobileScan Technologies, a portable imaging device developer, broadening its footprint in the point‐of‐care and mobile diagnostic segment.

Key Players:
FUJIFILM Healthcare Americas Corporation, Hitachi Medical Corporation, Hologic Inc., Philips Healthcare, GE Healthcare, Canon Medical Systems USA, Samsung Medison America, Mindray North America, Butterfly Network, and Siemens Healthineers USA.

Buy Now & Unlock 360° Market Intelligence:-https://www.datamintelligence.com/buy-now-page?report=north-america-diagnostic-imaging-market?Juli

Market Segmentation:

By Type
In North America, X-ray systems dominate the diagnostic imaging devices market with approximately 28% share, driven by widespread adoption in general diagnostics, orthopedics, and emergency medicine due to affordability and quick imaging capabilities. MRI systems hold around 22%, supported by demand for high-resolution soft-tissue imaging in neurology, oncology, and musculoskeletal diagnostics. Computed Tomography (CT) scanners account for 20%, reflecting their critical role in trauma care, oncology, and advanced diagnostic procedures. Ultrasound devices represent 15%, fueled by use in obstetrics, cardiology, and point-of-care applications. SPECT imaging systems hold 7%, primarily in cardiology and nuclear medicine, while tactile imaging and functional near-infrared spectroscopy (fNIRS) together represent the remaining 8%, growing due to specialized applications in research, neurology, and non-invasive monitoring.

By Application
The North America market is primarily segmented by clinical applications, with oncology leading at 27%, driven by the increasing prevalence of cancer and demand for early detection through advanced imaging. Cardiology follows with 22%, reflecting rising cardiovascular disease incidence and adoption of cardiac imaging systems. Neurology accounts for 18%, supported by MRI and CT usage for stroke, brain disorders, and neurodegenerative disease monitoring. Orthopedic applications hold 15%, primarily using X-ray, CT, and MRI for musculoskeletal diagnostics and surgical planning. The remaining 18% includes other specialized applications such as obstetrics, urology, and general diagnostics.

By End-User
Hospitals are the largest end-users in North America, representing approximately 48% of the market, due to high patient volumes, integrated diagnostic departments, and comprehensive imaging infrastructure. Diagnostic imaging centers account for about 35%, benefiting from outsourced radiology services and expansion of standalone imaging facilities. Ambulatory surgical centers and specialty clinics represent 12%, utilizing portable and compact imaging devices for focused clinical needs. The remaining 5% is shared by research institutes and academic centers, leveraging imaging technologies for clinical research, education, and innovation.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/north-america-diagnostic-imaging-market?Juli

Regional Insights

United States dominates the North America diagnostic imaging market, accounting for approximately 70% of the regional share. Growth is driven by advanced healthcare infrastructure, high adoption of AI-powered imaging systems, strong reimbursement policies, and increasing investments in hospital imaging departments.

Canada holds around 20% of the North American market, supported by expanding public and private healthcare facilities, rising adoption of high-resolution MRI and CT scanners, and government initiatives to improve access to diagnostic imaging services.

Mexico and other countries in North America represent the remaining 10%, with market growth driven by the modernization of healthcare infrastructure, increased demand for diagnostic imaging in urban centers, and rising awareness of chronic diseases.

Market Drivers:
Rising Geriatric Population
The growing elderly population in North America is a key driver of the diagnostic imaging market. Age-related chronic diseases and conditions such as cancer, cardiovascular disease, and osteoarthritis are increasingly prevalent among the elderly, creating a greater need for early detection, accurate diagnosis, and ongoing monitoring.

This trend has driven demand for a wide range of imaging modalities, including X-rays, MRI, and CT scans, as healthcare providers seek to deliver comprehensive diagnostic services. Hospitals and diagnostic centers are continuously investing in advanced imaging technologies to meet the healthcare needs of an aging population, thereby fueling market growth.

As a result, the North America diagnostic imaging market is expanding rapidly, adapting to evolving healthcare demands while increasing access to high-quality imaging solutions for older adults.

Market Restraints
High Costs of Diagnostic Imaging Equipment
The high acquisition and operational costs of diagnostic imaging systems, such as MRI, PET, and CT scanners, remain a major restraint for market growth. Smaller clinics, hospitals with limited budgets, and mid-income facilities may find it challenging to adopt high-end imaging devices due to substantial upfront investment and ongoing maintenance expenses.

This financial barrier can slow adoption rates in certain healthcare segments and regions, potentially limiting overall market expansion despite the growing demand for advanced diagnostic solutions. Cost-effective models, leasing options, and government support programs are increasingly necessary to facilitate broader access to these technologies.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.